Clinical Orthopaedics and Related Research®

, Volume 470, Issue 10, pp 2785–2799 | Cite as

Is There Really No Benefit of Vertebroplasty for Osteoporotic Vertebral Fractures? A Meta-analysis

  • Ming-Min Shi
  • Xun-Zi Cai
  • Tiao Lin
  • Wei Wang
  • Shi-Gui Yan
Survey

Abstract

Background

Osteoporotic vertebral compressed fractures (VCFs) are the most common osteoporotic fractures. Although percutaneous vertebroplasty (PVP) reportedly relieves pain and improves function, a recent pooled analysis from two multicenter randomized controlled trials concluded the improvement in pain and disability treated with PVP was similar to those with sham surgery.

Questions/Purpose

Using meta-analysis we therefore asked whether compared with either nonoperative therapy or a sham injection for patients with VCF, PVP would (1) better relieve pain, (2) provide greater improvement in pain-related disability, and (3) increase the recurrence of vertebral fractures.

Methods

We searched PubMed, EMBASE, Medline, and the Cochrane library using the keywords “vertebroplasty AND osteoporosis OR fracture”. We included nine of the 469 articles identified. Using a random effects model, we calculated the weighted mean differences to evaluate the pain reduction at different times as the primary outcome. Pain-related disability was assessed by a quality of life (QOL) measure. Improvement of QOL and recurrence of vertebral fractures were the secondary outcomes. We used subgroup analysis to reinvestigate pain relief and function improvement of PVP based on two different controls: nonoperative therapy and sham injection. The total number of patients was 886.

Results

Pain scoring was similar between the PVP group and the sham injection group at 1 to 29 days and 90 days. However, compared with nonoperative therapy, PVP reduced pain at all times studied. QOL in the PVP group was improved or tended to be improved compared with QOL for both control groups. The risk of new fractures was similar between the PVP groups and both control groups.

Conclusions

Different control groups may have accounted for the different conclusions in the literature regarding the ability of PVP to relieve pain and restore function recovery. Compared with nonoperative treatment PVP relieved pain better and improved QOL. PVP did not increase the risk of new fractures.

Level of Evidence

Level II, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Notes

Acknowledgments

We thank all the corresponding authors from the included trials for their kind assistance in obtaining additional data that contributed to our meta-analysis.

References

  1. 1.
    Alfonso Olmos M, Silva Gonzalez A, Duart Clemente J, Villas Tome C. Infected vertebroplasty due to uncommon bacteria solved surgically: a rare and threatening life complication of a common procedure: report of a case and a review of the literature. Spine (Phila Pa 1976). 2006;31:E770–E773.CrossRefGoogle Scholar
  2. 2.
    Alvarez L, Alcaraz M, Perez-Higueras A, Granizo JJ, de Miguel I, Rossi RE, Quinones D. Percutaneous vertebroplasty: functional improvement in patients with osteoporotic compression fractures. Spine (Phila Pa 1976). 2006;31:1113–1118.CrossRefGoogle Scholar
  3. 3.
    Anselmetti GC, Manca A, Hirsch J, Montemurro F, Isaia G, Osella G, Chiara G, Iussich G, Debernardi F, Regge D. Percutaneous vertebroplasty in osteoporotic patients: an institutional experience of 1,634 patients with long-term follow-up. J Vasc Interv Radiol. 2011;22:1714–1720.PubMedCrossRefGoogle Scholar
  4. 4.
    Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT, Hill S, Jaeschke R, Liberati A, Magrini N, Mason J, O’Connell D, Oxman AD, Phillips B, Schünemann H, Edejer TT, Vist GE, Williams JW Jr; GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005;5:25.PubMedCrossRefGoogle Scholar
  5. 5.
    Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine (Phila Pa 1976). 2000;25:923–928.CrossRefGoogle Scholar
  6. 6.
    Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301:513–521.PubMedCrossRefGoogle Scholar
  7. 7.
    Boluki D. [Surgical therapy of osteoporotic vertebral body fractures] [in German]. Z Rheumatol. 2011;70:45–55; quiz 55.Google Scholar
  8. 8.
    Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557–568.PubMedCrossRefGoogle Scholar
  9. 9.
    Chang CY, Teng MM, Wei CJ, Luo CB, Chang FC. Percutaneous vertebroplasty for patients with osteoporosis: a one-year follow-up. Acta Radiol. 2006;47:568–573.PubMedCrossRefGoogle Scholar
  10. 10.
    Chen HL, Wong CS, Ho ST, Chang FL, Hsu CH, Wu CT. A lethal pulmonary embolism during percutaneous vertebroplasty. Anesth Analg. 2002;95:1060–1062.PubMedGoogle Scholar
  11. 11.
    Chin DK, Kim YS, Cho YE, Shin JJ. Efficacy of postural reduction in osteoporotic vertebral compression fractures followed by percutaneous vertebroplasty. Neurosurgery. 2006;58:695–700.PubMedCrossRefGoogle Scholar
  12. 12.
    Cohen LD. Fractures of the osteoporotic spine. Orthop Clin North Am. 1990;21:143–150.PubMedGoogle Scholar
  13. 13.
    Cortet B, Cotten A, Boutry N, Flipo RM, Duquesnoy B, Chastanet P, Delcambre B. Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study. J Rheumatol. 1999;26:2222–2228.PubMedGoogle Scholar
  14. 14.
    Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med. 2003;114:257–265.PubMedCrossRefGoogle Scholar
  15. 15.
    Farrokhi MR, Alibai E, Maghami Z. Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. J Neurosurg Spine. 2011;14:561–569.PubMedGoogle Scholar
  16. 16.
    Farrokhi MR, Torabinezhad S, Ghajar KA. Pilot study of a new acrylic cage in a dog cervical spine fusion model. J Spinal Disord Tech. 2010;23:272–277.PubMedCrossRefGoogle Scholar
  17. 17.
    Furlan AD, Pennick V, Bombardier C, van Tulder M; Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976). 2009;34:1929–1941.CrossRefGoogle Scholar
  18. 18.
    Grados F, Depriester C, Cayrolle G, Hardy N, Deramond H, Fardellone P. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford). 2000;39:1410–1414.CrossRefGoogle Scholar
  19. 19.
    Grafe IA, Noldge G, Weiss C, Libicher M, Baier M, Nawroth P, Meeder PJ, Wiedenhöfer B, Kasperk C. Prediction of immediate and long-term benefit after kyphoplasty of painful osteoporotic vertebral fractures by preoperative MRI. Eur J Trauma Emerg Surg. 2011;37:379–386.CrossRefGoogle Scholar
  20. 20.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.PubMedCrossRefGoogle Scholar
  21. 21.
    Hiwatashi A, Moritani T, Numaguchi Y, Westesson PL. Increase in vertebral body height after vertebroplasty. Am J Neuroradiol. 2003;24:185–189.PubMedGoogle Scholar
  22. 22.
    Huskisson EC. Measurement of pain. J Rheumatol. 1982;9:768–769.PubMedGoogle Scholar
  23. 23.
    Jensen ME, McGraw JK, Cardella JF, Hirsch JA. Position statement on percutaneous vertebral augmentation: a consensus statement developed by the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, and American Society of Spine Radiology. J Neurointerv Surg. 2009;1:181–185.PubMedCrossRefGoogle Scholar
  24. 24.
    Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733.PubMedCrossRefGoogle Scholar
  25. 25.
    Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215–1220.PubMedCrossRefGoogle Scholar
  26. 26.
    Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569–579.PubMedCrossRefGoogle Scholar
  27. 27.
    Klazen CA, Lohle PN, de Vries J, Jansen FH, Tielbeek AV, Blonk MC, Venmans A, van Rooij WJ, Schoemaker MC, Juttmann JR, Lo TH, Verhaar HJ, van der Graaf Y, van Everdingen KJ, Muller AF, Elgersma OE, Halkema DR, Fransen H, Janssens X, Buskens E, Mali WP. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet. 2010;376:1085–1092.PubMedCrossRefGoogle Scholar
  28. 28.
    Lee BJ, Lee SR, Yoo TY. Paraplegia as a complication of percutaneous vertebroplasty with polymethylmethacrylate: a case report. Spine (Phila Pa 1976). 2002;27:E419–E422.Google Scholar
  29. 29.
    Lin WC, Lee CH, Chen SH, Lui CC. Unusual presentation of infected vertebroplasty with delayed cement dislodgment in an immunocompromised patient: case report and review of literature. Cardiovasc Intervent Radiol. 2008;31(suppl 2):231–235.CrossRefGoogle Scholar
  30. 30.
    Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA, McCloskey E, Minne H, Reeve J, Reginster JY, Scholz M, Todd C, de Vernejoul MC. Wiklund I.Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int. 1999;10:150–160.PubMedCrossRefGoogle Scholar
  31. 31.
    Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: a preliminary report of a randomized, double-blind controlled trial. Pain Physician. 2008;11:491–504.PubMedGoogle Scholar
  32. 32.
    McGraw JK, Cardella J, Barr JD, Mathis JM, Sanchez O, Schwartzberg MS, Swan TL, Sacks D; Society of Interventional Radiology Standards of Practice Committee. Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. (Republished from J Vasc Interv Radiol. 2003;14:827-831.) J Vasc Interv Radiol. 2003;14:S311–S315.PubMedCrossRefGoogle Scholar
  33. 33.
    McGraw JK, Cardella J, Barr JD, Mathis JM, Sanchez O, Schwartzberg MS, Swan TL, Sacks D; Society of Interventional Radiology Standards of Practice Committee. Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol. 2003;14:827–831.PubMedCrossRefGoogle Scholar
  34. 34.
    Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299.PubMedCrossRefGoogle Scholar
  35. 35.
    Phillips FM. Minimally invasive treatments of osteoporotic vertebral compression fractures. Spine (Phila Pa 1976). 2003;28(15 suppl):S45–S53.Google Scholar
  36. 36.
    Ploeg WT, Veldhuizen AG, The B, Sietsma MS. Percutaneous vertebroplasty as a treatment for osteoporotic vertebral compression fractures: a systematic review. Eur Spine J. 2006;15:1749–1758.PubMedCrossRefGoogle Scholar
  37. 37.
    Rousing R, Andersen MO, Jespersen SM, Thomsen K, Lauritsen J. Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study. Spine (Phila Pa 1976). 2009;34:1349–1354.Google Scholar
  38. 38.
    Shih MS, Cook MA, Spence CA, Palnitkar S, McElroy H, Parfitt AM. Relationship between bone formation rate and osteoblast surface on different subdivisions of the endosteal envelope in aging & osteoporosis. Bone. 1993;14:519–521.PubMedCrossRefGoogle Scholar
  39. 39.
    Staples MP, Kallmes DF, Comstock BA, Jarvik JG, Osborne RH, Heagerty PJ, Buchbinder R. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ. 2011;343:d3952.PubMedCrossRefGoogle Scholar
  40. 40.
    Sun G, Jin P, Li M, Liu XW, Li FD. Height restoration and wedge angle correction effects of percutaneous vertebroplasty: association with intraosseous clefts. Eur Radiol. 2011:21:2597–2603.PubMedCrossRefGoogle Scholar
  41. 41.
    Sun G, Jin P, Li M, Lu Y, Ding J, Liu X, Li F. Percutaneous cementoplasty for painful osteolytic humeral metastases: initial experience with an innovative technique. Skeletal Radiol. 2011;40:1345–1348.PubMedCrossRefGoogle Scholar
  42. 42.
    Tamayo-Orozco J, Arzac-Palumbo P, Peon-Vidales H, Mota-Bolfeta R, Fuentes F. Vertebral fractures associated with osteoporosis: patient management. Am J Med. 1997;103(2A):44S–50S; discussion 48S–50S.Google Scholar
  43. 43.
    Tan BHM, Hee HT. Analysis of the effects of percutaneous vertebroplasty in osteoporotic compression fractures. J Orthopaedics. 2011;8(3):e9. Available at: http://www.jortho.org/2011/8/3/e9. Accessed April 26, 2012.
  44. 44.
    Trout AT, Kallmes DF. Does vertebroplasty cause incident vertebral fractures? A review of available data. AJNR Am J Neuroradiol. 2006;27:1397–1403.PubMedGoogle Scholar
  45. 45.
    Trout AT, Kallmes DF, Gray LA, Goodnature BA, Everson SL, Comstock BA, Jarvik JG. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol. 2005;26:2652–2657.PubMedGoogle Scholar
  46. 46.
    Uebelhart B, Casez P, Rizzoli R, Louis-Simonet M. Prophylactic injection of methylmetacrylate in vertebrae located between two previously cemented levels does not prevent a subsequent compression fracture in a patient with bone fragility. Joint Bone Spine. 2008;75:322–324.PubMedCrossRefGoogle Scholar
  47. 47.
    Voormolen MH, Mali WP, Lohle PN, Fransen H, Lampmann LE, van der Graaf Y, Juttmann JR, Jansssens X, Verhaar HJ. Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol. 2007;28:555–560.PubMedGoogle Scholar
  48. 48.
    Voormolen MH, van Rooij WJ, Sluzewski M, van der Graaf Y, Lampmann LE, Lohle PN, Juttmann JR. Pain response in the first trimester after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures with or without bone marrow edema. AJNR Am J Neuroradiol. 2006;27:1579–1585.PubMedGoogle Scholar
  49. 49.
    Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532.PubMedCrossRefGoogle Scholar
  50. 50.
    Wang HK, Lu K, Liang CL, Weng HC, Wang KW, Tsai YD, Hsieh CH, Liliang PC. Comparing clinical outcomes following percutaneous vertebroplasty with conservative therapy for acute osteoporotic vertebral compression fractures. Pain Med. 2010;11:1659–1665.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2012

Authors and Affiliations

  • Ming-Min Shi
    • 1
  • Xun-Zi Cai
    • 1
  • Tiao Lin
    • 1
  • Wei Wang
    • 1
  • Shi-Gui Yan
    • 1
  1. 1.Department of Orthopaedic Surgery, Second Affiliated Hospital, School of MedicineZhejiang UniversityHangzhouPeople’s Republic of China

Personalised recommendations